Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

Home

GMED

G

Globus Medical, Inc. (GMED)

NYQ – Real Time Price. Currency in USD

83.78

-2.72 (-3.14%)

At close: Mar 27, 2026, 4:00 PM EDT

84.13

+0.35 (0.42%)

After-hours: Mar 27, 2026, 8:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Why Is Globus Medical (GMED) Down 9.2% Since Last Earnings Report?

Why Is Globus Medical (GMED) Down 9.2% Since Last Earnings Report?

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

Globus Medical Announces Board Departure

Globus Medical Announces Board Departure

AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, PhD, a Director of Globus Medical Inc., notified the company of his decision to step down from the Board of Directors effective immediately and will not seek re-election at the Annual Meeting of Stockholders on June 3, 2026.

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.

5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside

5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside

ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.

Bears are Losing Control Over Globus Medical (GMED), Here's Why It's a 'Buy' Now

Bears are Losing Control Over Globus Medical (GMED), Here's Why It's a 'Buy' Now

Globus Medical (GMED) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Why Top-Tier Robotic Surgery Name Globus Medical Is Getting 'Aggressive' In 2026

Why Top-Tier Robotic Surgery Name Globus Medical Is Getting 'Aggressive' In 2026

Globus Medical stock has been a on a hot streak since early November thanks to a resurgence for its robotics division and strong U.S. spine segment.

Here's Why Globus Medical (GMED) is a Strong Momentum Stock

Here's Why Globus Medical (GMED) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Videos

No Data

There is no data to display

Press releases

Globus Medical Announces Board Departure

Globus Medical Announces Board Departure

AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, PhD, a Director of Globus Medical Inc., notified the company of his decision to step down from the Board of Directors effective immediately and will not seek re-election at the Annual Meeting of Stockholders on June 3, 2026.

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025.

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2025. The company anticipates fourth quarter 2025 sales of approximately $823.2 million, an increase of 25.2 percent over the fourth quarter 2024 on an as-reported basis. Full year 2025 sales are expected to be approximately $2.936 billion, an increase of 16.5 percent over the prior year on an as-reported basis.

Globus Medical Reports Third Quarter 2025 Results

Globus Medical Reports Third Quarter 2025 Results

AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025.